Comparison of horse and rabbit antithymocyte globulin in
Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood by Ayami Yoshimi, Marry M. van den Heuvel-Eibrink, Irith Baumann, Stephan Schwarz, Ingrid Simonitsch-Klupp, Pascale de Paepe, Vit Campr, Gitte Birk Kerndrup, Maureen O’Sullivan, Rita Devito, Roos Leguit, Miguel Hernandez, Michael Dworzak, Barbara de Moerloose, Jan Starý, Henrik Hasle, Owen P. Smith, Marco Zecca, Albert Catala, Markus Schmugge, Franco Locatelli, Monika Führer, Alexandra Fischer, Anne Guderle, Peter Nöllke, Brigitte Strahm, and Charlotte M. Niemeyer haematol Volume 99(4): 656 -663 March 31, 2014 © 2014 by Ferrata Storti Foundation
Overview of the 450 patients with refractory cytopenia of childhood. Ayami Yoshimi et al. Haematologica 2014; 99: 656 -663 © 2014 by Ferrata Storti Foundation
Clinical characteristics of the 95 patients with refractory cytopenia of childhood who received immunosuppressive therapy with either horse or rabbit antithymocyte globulin. Ayami Yoshimi et al. Haematologica 2014; 99: 656 -663 © 2014 by Ferrata Storti Foundation
Clinical characteristics prior to immunosuppressive therapy in responders and non-responders: univariate and multivariate analysis. Ayami Yoshimi et al. Haematologica 2014; 99: 656 -663 © 2014 by Ferrata Storti Foundation
Overall (A–B), transplantation-free (C), and failure-free (D) survival rates after immunosuppressive therapy (IST) in children with refractory cytopenia of childhood treated with either horse antithymocyte globulin (horse-ATG) or rabbit-ATG. Ayami Yoshimi et al. Haematologica 2014; 99: 656 -663 © 2014 by Ferrata Storti Foundation
- Slides: 5